Selling Clinical Biospecimens: Guidance for Researchers and Private Industry

&
Journal of Law, Medicine and Ethics 51 (2):429-436 (2023)
  Copy   BIBTEX

Abstract

The recently revised Common Rule requires that donors of biospecimens for research be informed if their specimens might be used for commercial profit. The Common Rule, however, does not apply to sharing or selling de-identified biospecimens that are “leftover” from clinical uses. As a result, many medical researchers remain uncertain of their legal and ethical obligations when a commercial entity expresses interest in these specimens.

Categories

Keywords

Reprint years

DOI

10.1017/jme.2023.83

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,261

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Negotiating Commercial Interests in Biospecimens.Jessica L. Roberts - 2017 - Journal of Law, Medicine and Ethics 45 (1):138-141.
Allocation of scarce biospecimens for use in research.Leah Pierson, Sophia Gibert, Benjamin Berkman, Marion Danis & Joseph Millum - 2021 - Journal of Medical Ethics 47 (11):740-743.
Take Another Little Piece of My Heart1: Regulating the Research Use of Human Biospecimens.Gail H. Javitt - 2013 - Journal of Law, Medicine and Ethics 41 (2):424-439.
Take Another Little Piece of My Heart: Regulating the Research Use of Human Biospecimens.Gail H. Javitt - 2013 - Journal of Law, Medicine and Ethics 41 (2):424-439.
Wanted: Human Biospecimens.Karen J. Maschke - 2010 - Hastings Center Report 40 (5):21-23.
Waving Goodbye to Waivers of Consent.Jeffrey R. Botkin - 2015 - Hastings Center Report 45 (6):inside back cover-inside back co.
IRB practices and policies regarding the secondary research use of biospecimens.Aaron J. Goldenberg, Karen J. Maschke, Steven Joffe, Jeffrey R. Botkin, Erin Rothwell, Thomas H. Murray, Rebecca Anderson, Nicole Deming, Beth F. Rosenthal & Suzanne M. Rivera - 2015 - BMC Medical Ethics 16 (1):32.
Regulating Research with Biospecimens under the Revised Common Rule.Holly Fernandez Lynch & Michelle N. Meyer - 2017 - Hastings Center Report 47 (3):3-4.
A Trade Secret Model for Genomic Biobanking.John M. Conley, Robert Mitchell, R. Jean Cadigan, Arlene M. Davis, Allison W. Dobson & Ryan Q. Gladden - 2012 - Journal of Law, Medicine and Ethics 40 (3):612-629.
Human Biospecimens Come from People.Tom Tomlinson & Raymond G. De Vries - 2019 - Ethics and Human Research 41 (2).
Research based on existing clinical data and biospecimens: a systematic study of patients’ opinions.Arne Einar Vaaler, Linda Tømmerdal Roten & Hilde Eikemo - 2022 - BMC Medical Ethics 23 (1):1-8.
A survey of patient perspectives on the research use of health information and biospecimens.Stacey A. Page, Kiran Pohar Manhas & Daniel A. Muruve - 2016 - BMC Medical Ethics 17 (1):48.
Conscience, Courage, and “Consent”.Mark A. Hall & Nancy M. P. King - 2016 - Hastings Center Report 46 (2):30-32.
Implementing Regulatory Broad Consent Under the Revised Common Rule: Clarifying Key Points and the Need for Evidence.Holly Fernandez Lynch, Leslie E. Wolf & Mark Barnes - 2019 - Journal of Law, Medicine and Ethics 47 (2):213-231.
Confronting Biospecimen Exceptionalism in Proposed Revisions to the Common Rule.Holly Fernandez Lynch, Barbara E. Bierer & I. Glenn Cohen - 2016 - Hastings Center Report 46 (1):4-5.

Analytics

Added to PP
2023-09-02

Downloads
10 (#1,198,690)

6 months
8 (#370,225)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Peter H. Schwartz
Indiana University Purdue University, Indianapolis

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references